Physician profile
Andrew D Doering
NPI 1699119172
$1,806.53
in general payments reported to CMS, 2019-2025
8 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2021: $104 · 2022: $300 · 2023: $219 · 2024: $591 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $514.90 | 2022-2024 | Perclot, Tisseel, Floseal |
| Axonics, INC. | $421.53 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $393.06 | 2019-2024 | Solyx Sis System, Advantage System |
| Medtronic, INC. | $181.31 | 2023-2025 | Interstim, Altaviva |
| Coopersurgical, INC. | $140.85 | 2019-2025 | Ally II Ups |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Merck Sharp & Dohme LLC | $14.60 | 2019 | |
| Intuitive Surgical, INC. | $8.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Doering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.